Bidica

Bidica

Manufacturer:

Pacific Pharma (Korea)

Distributor:

AA Medical
Full Prescribing Info
Contents
Biphenyl dimethyl dicarboxylate.
Indications/Uses
Treatment of chronic and persistent hepatitis that is associated with a high ALT level or drug-induced high transaminase level.
Dosage/Direction for Use
Adults: Usual dosage is 1-2 tablets 3 times daily. Dosage can be increased by the direction of a physician.
Contraindications
None reported.
Warnings
Bidica should be used with caution in patients with chronic active hepatitis and cirrhosis.
In patients with elevated ALT level during administration of Bidica, ALT can increase after the end of administration, but it can be improved through re-administration of Bidica.
Use in pregnancy & lactation: Bidica should not be administered in pregnant and nursing mother.
Use in children: Bidica should be administered to young child in reduced dosage.
Use in the elderly: Usually administered in reduced quantity because of their depreciated physiology.
Special Precautions
Nausea may occur rarely.
Use In Pregnancy & Lactation
Bidica should not be administered in pregnant and nursing mother.
Adverse Reactions
If thirst, nausea, rash occurs, the patient should administer Bidica with an anti-hypersensitivity agent.
If temporary jaundice occurs, the patient should discontinue the administration or administer Bidica with treatment for jaundice.
Nausea and abdominal distention can occur rarely but the symptoms are lost soon.
Drug Interactions
When Bidica is administered concomitantly with inosine, relapsed ALT's rise can improve.
Storage
Store below 30°C. Protect from sunlight and humidity.
Shelf-Life: 3 years.
ATC Classification
A05BA - Liver therapy ; Used in liver therapy.
Presentation/Packing
Tab (oblong and white) 25 mg x 12 x 10's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in